Hosted by Parker Institute for Cancer Immunotherapy · 🇺🇸 US · EN · 15 episodes
Established thought leaders with verified media credentials.
From Bench to Fireside™ is a podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients.
Parker Institute for Cancer Immunotherapy hosts From Bench to Fireside, a science show with 15 episodes published.
What if our immune cells could be reprogrammed to sense, decide and act—outsmarting even the most elusive tumors? In this episode of From Bench to Fireside Kole Roybal, PhD, Director of the Parker Institute of Cancer Imm
In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Roberta Zappasodi, PhD, Assistant Professor of Hematology a
In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Roberta Zappasodi, PhD, Assistant Professor of Hematology a
In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Antoni Ribas, MD, PhD, Director of the PICI Center at UCLA,
In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Elizabeth Mittendorf, MD, PhD, MHCM, FASCO - Director of th
In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Carl June, MD, Director of the PICI Center at the Universit
2022 Parker Bridge Fellow at UCLA, Katie Campbell, PhD, is a rising star in cancer informatics. In this episode, Katie talks with PICI Chief Scientific Officer John Connolly, PhD, about her journey into personalized medi
In this episode, Robbie Majzner, MD, a PICI Investigator at the Dana-Farber Cancer Institute, sits down with PICI Chief Scientific Officer John Connolly, PhD, to discuss efforts to engineer next-generation CAR T cells us
In this episode, PICI Member Researcher Evanna Mills, PhD, a distinguished professor at Dana-Farber Cancer Institute and Harvard Medical School, joins PICI Chief Scientific Officer John Connolly, PhD, to discuss her grou
In this episode, Justin Eyquem, PhD, Parker Senior Fellow and PICI Member Researcher at the University of California, San Francisco, talks about his visionary work pioneering CAR-T cell therapies and synthetic biology wi
In this episode, Nina Bhardwaj, MD, PhD, a PICI Network Investigator and the Director of Immunotherapy at the Icahn School of Medicine at Mount Sinai, sits down with PICI Chief Scientific Officer John Connolly, PhD, for
In this episode, physician-scientist Christopher A. Klebanoff, MD, a PICI Network Investigator at Memorial Sloan Kettering Cancer Center, provides an inside look at his groundbreaking research on optimizing T-cell activa
In this episode, pioneering researcher Crystal Mackall, MD, Center Director for the PICI Center at Stanford Medicine, talks through what led to her contributions to cancer immunotherapy, including her point of view on ta
This episode of “From Bench to Fireside” is a special one for PICI that marks a network expansion with Weill Cornell Medicine joining as our newest PICI Center. The partnership will build upon PICI’s work to accelerate r
For more than three decades, Dr. Lewis Lanier has researched natural killer (NK) cells and their innate and adaptive responses to pathogens and cancer. The Parker Institute for Cancer Immunotherapy’s Chief Scientific Off
Introducing From Bench to Fireside™, a new podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Hosted by PICI Chief Scientific O
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
From Bench to Fireside has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
From Bench to Fireside is hosted by Parker Institute for Cancer Immunotherapy. The show is categorised under science and has published 15 episodes.
From Bench to Fireside has published 15 episodes.
From Bench to Fireside regularly covers science. It sits in the science category.
From Bench to Fireside is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
From Bench to Fireside hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of From Bench to Fireside average 32 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates From Bench to Fireside's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 7 days ago.
